SARS-CoV-2 vaccine uptake and risks of severe COVID-19 disease among people prescribed opioid agonist therapy in Scotland.

Alan C YeungMax WilkinsonJen BishopBob TaylorNorah PalmateerLee BarnsdaleJaroslaw LangClaire CameronDuncan McCormickTracey CluskerAndrew McAuleySharon Hutchinson

Published in: Journal of epidemiology and community health (2024)

The widening gap in vaccine coverage for those prescribed OAT, compared with the general population, is likely to have exacerbated the risk of severe COVID-19 in this population over the pandemic. However, continued OAT use may have provided protection from severe COVID-19 among those with opioid dependence.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
early onset
chronic pain
pain management
drug induced
stem cells
healthcare
cell therapy
smoking cessation